Clinical Study

Study evaluates zinc in treatment of ADHD

Format: PDF file | Document type: Clinical Study | Promoted Content

This Clinical Study has been written by Albion Human Nutrition , and any views and opinions expressed do not necessarily reflect those of

Study evaluates zinc in treatment of ADHD

Symptoms of attention-deficit/hyperactivity (ADHD) disorder are often treated with methylphenidate and amphetamine. This study evaluates the of zinc glycinate as a cofactor for metabolism relative to neurotransmitters, prostaglandins, and melatonin, which indirectly affect dopamine metabolism. One of the findings from the study was a reduction of the dose of stimulant (37%) when a using 30 mg. of zinc per day. This suggests the need to further research the use of zinc with optimal doses of stimulants relative to ADHD.

Related resources from Albion Human Nutrition

Show more

Supplier info centre